Gilead Sciences, Inc.
Quinoline derivatives
Last updated:
Abstract:
The present disclosure provides a compound of Formula (I): ##STR00001## or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
Status:
Grant
Type:
Utility
Filling date:
29 Oct 2019
Issue date:
14 Sep 2021